The correlation between the expression levels of UCA1 and PGM5-AS1 and the clinicopathological characteristics of CRC patients are analyzed (Table 2), which showed that the expression of UCA1 nor PGM5-AS1 had no correlation with age, gender, differentiation, and AJCC stage of the patients. This evidence concerns the gene UCA1 and colorectal carcinoma.